Silencing miR-126-5p protects trabecular meshwork cells against chronic oxidative injury by upregulating HSPB8 to activate PI3K/AKT pathway
Journal of Molecular Histology · 2025
DOI: 10.1007/s10735-024-10337-8 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Molecular Histology, 2025. Verfasst von Tianqi Jia und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Ophthalmology, Harbin Bright Eye Hospital, No.563 Xianfeng Road, Nangang District, Harbin, 150000, China. Hauptthemen laut MEDLINE: Trabecular Meshwork, MicroRNAs, Proto-Oncogene Proteins c-akt, Phosphatidylinositol 3-Kinases. Die Arbeit nennt 48 Literaturangaben.
Abstract (Originalsprache)
Chronic oxidative stress (COS) is related to the pathophysiology of the trabecular meshwork (TM) in glaucoma. MicroRNAs (miRNAs) have a key role in the oxidative stress-mediated glaucoma. This work investigated the function of miR-126-5p in human trabecular meshwork cells (TMCs) under chronic oxidative stress (COS). The miR-126-5p inhibitor was transfected into TMCs to assess the function of miR-126-5p. The targets of miR-126-5p were predicted by bioinformatic analysis. A luciferase assay was applied to test the relationship between miR-126-5p and its target. Cell proliferation was assessed using MTT. Flow cytometry and TUNEL were used for the assessment of apoptosis. We found that the miR-126-5p level was elevated in TMCs exposed to COS. MiR-126-5p inhibitor markedly promoted TMC proliferation and inhibited the increases in apoptosis and extracellular matrix (ECM) proteins induced by COS. Heat shock protein B8 (HSPB8) was identified to be targeted by miR-126-5p. MiR-126-5p inhibitor restored the expression level of HSPB8 in TMCs under COS. Additionally, miR-126-5p depletion activated PI3K/AKT signaling in TMCs by upregulating HSPB8. HSPB8 downregulation or LY294002 treatment prevented the effects mediated by miR-126-5p inhibition on apoptosis and ECM in COS-treated TMCs. Overall, silencing miR-126-5p protects TMCs against COS-induced injury by upregulating HSPB8 to activate PI3K/AKT signaling.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Ophthalmology, Harbin Bright Eye Hospital, No.563 Xianfeng Road, Nangang District, Harbin, 150000, China.
- Department of Ophthalmology, Fengtai District Hospital of Traditional Chinese Medicine, No.3 Nanyuan CCBA Hutong, Fengtai District, Beijing, 100076, China.
- Department of Ophthalmology, First Affilliated Hospital, Heilongjiang University of Chinese Medicine, No.26 Heping Road, Xiangfang District, Harbin, 150000, China. Ab52591111@163.com.
Zitieren
APA
Jia, T., Guo, Y., & Zhao, X. (2025). Silencing miR-126-5p protects trabecular meshwork cells against chronic oxidative injury by upregulating HSPB8 to activate PI3K/AKT pathway. Journal of Molecular Histology. https://doi.org/10.1007/s10735-024-10337-8
Vancouver
Jia T, Guo Y, Zhao X. Silencing miR-126-5p protects trabecular meshwork cells against chronic oxidative injury by upregulating HSPB8 to activate PI3K/AKT pathway. Journal of Molecular Histology. 2025. doi:10.1007/s10735-024-10337-8
BibTeX
@article{Jia2025,
author = {Jia, Tianqi and Guo, Yujia and Zhao, Xiaolong},
title = {Silencing miR-126-5p protects trabecular meshwork cells against chronic oxidative injury by upregulating HSPB8 to activate PI3K/AKT pathway},
journal = {Journal of Molecular Histology},
year = {2025},
doi = {10.1007/s10735-024-10337-8}
}
EUVIMED